Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues (Q48048218)

8 February 2018

http://europepmc.org/abstract/MED/27435858

title

Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues (English)

1 reference

8 February 2018

http://europepmc.org/abstract/MED/27435858

main subject

NF-κB

0 references

prostatic hypertrophy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Khalil Ahmed

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

author name string

Fatima Qaiser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Sarah Sadiq

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Iqbal Muhammad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Rubina Younis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Shoaib Naiyar Hashmi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Badar Murtaza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Thomas S Rector

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

Abdul Khaliq Naveed

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

publication date

19 July 2016

1 reference

8 February 2018

http://europepmc.org/abstract/MED/27435858

published in

Molecular and Cellular Biochemistry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

volume

420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

page(s)

43-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow.

16 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Predicting CK2 beta-dependent substrates using linear patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Protein kinase CK2 in health and disease: Protein kinase CK2: an ugly duckling in the kinome pond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Protein kinase CK2 in health and disease: CK2: a key player in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Constitutive phosphorylation of I kappa B alpha by casein kinase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

The complexity of NF-κB signaling in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

NF-κB and androgen receptor variant expression correlate with human BPH progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

The Molecular Taxonomy of Primary Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Integrative clinical genomics of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

The Ki-67 protein: fascinating forms and an unknown function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Androgens and estrogens in benign prostatic hyperplasia: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

NF-κB nuclear localization and its prognostic significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2765-3

Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells

21 January 2018

1 reference

12 December 2020

Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.

1 reference

12 December 2020

Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.

1 reference

12 December 2020

Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer

1 reference

12 December 2020

Protein kinase CK2 in human diseases.

1 reference

12 December 2020

NF-kappaB in carcinoma therapy and prevention

1 reference

12 December 2020

TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma)

1 reference

12 December 2020

Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays

1 reference

12 December 2020

Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

1 reference

12 December 2020

Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation

1 reference

12 December 2020

Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P,

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate

1 reference

12 December 2020

Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation

1 reference

12 December 2020

10.1007/S11010-016-2765-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

release_vwwfz6yv65b3jnywabfsn7ao64

16 May 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668611&resulttype=core&format=json

16 May 2020

1 reference